Volume 25, Number 1—January 2019
Dispatch
Dengue Virus IgM Serotyping by ELISA with Recombinant Mutant Envelope Proteins
Table 1
Cohort, DENV serotype† |
No. samples |
Dominant serotype, no. (%) samples |
Serotype specificity‡ |
|
No. samples |
% Samples (95% CI) |
|||
Returning travelers | ||||
DENV-1 | 16 | 14 (87.50) | 14 | 87.50 (61.65–98.45) |
DENV-2 | 11 | 10 (90.91) | 8 | 72.73 (39.03–93.98) |
DENV-3 | 10 | 9 (90) | 9 | 90.00 (55.50–99.75) |
DENV-4 | 8 | 8 (100.00) | 7 | 87.50 (47.35–99.68) |
All serotypes |
45 |
41 (91.11) |
38 |
84.44 (70.54–93.51) |
Residents in DENV-endemic countries | ||||
Sri Lanka | ||||
DENV-1 | 23 | 16 (69.57) | 16 | 69.57 (47.08–86.79) |
DENV-2 | 14 | 13 (92.86) | 13 | 92.86 (66.13–99.82) |
DENV-4 | 6 | 6 (100.00) | 6 | 100.00 (54.07–100.00) |
All serotypes | 43 | 35 (81.40) | 35 | 81.40 (66.60–91.61) |
Vietnam | ||||
DENV-1 | 20 | 19 (95.00) | 19 | 95.00 (75.13–99.87) |
DENV-2 | 4 | 4 (100.00) | 4 | 100.00 (39.76–100.00) |
All serotypes | 24 | 23 (95.83) | 23 | 95.83 (78.88–99.89) |
Venezuela | ||||
DENV-4 | 5 | 4 (80.00) | 4 | 80.00 (23.36–99.49) |
Brazil | ||||
DENV-4 | 2 | 2 (100.00) | 2 | 100.00 (15.81–100.00) |
Total | ||||
DENV-1 | 43 | 35 (81.40) | 35 | 81.40 (66.60–91.61) |
DENV-2 | 18 | 17 (94.44) | 17 | 94.44 (72.71–99.86) |
DENV-4 | 13 | 12 (92.31) | 12 | 92.31 (76.55–99.81) |
All serotypes |
74 |
64 (86.49) |
64 |
86.49 (76.55–93.32) |
Total, all serotypes | 119 | 105 (88.24) | 102 | 85.71 (77.12–91.45) |
*DENV, dengue virus.
†Determined by PCR.
‡Determined by correspondence with PCR results.
Page created: December 18, 2018
Page updated: December 18, 2018
Page reviewed: December 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.